BATON ROUGE, La., Oct. 2 /PRNewswire-FirstCall/ -- Albemarle Corporation (NYSE: ALB), a world leader in custom fine chemical manufacturing, has completed its acquisition of the assets, fine chemistry services and pharmachemicals business associated with the South Haven, Mich. facility of DSM Pharmaceutical Products (DSM), a business group of Royal DSM NV. The acquisition was completed effective September 30, 2006.
